Skip to main content
. 2023 Aug 29;14:1195101. doi: 10.3389/fpsyt.2023.1195101

Table 1.

Demographic characteristics of participants (n = 192).

Item
Age, mean (SD) 34.4 (±9.9)
Sex, N (%)
Male 61 (31.8%)
Female 131 (68.2%)
Marital status, N (%)
Married 94 (49%)
Unmarried 81 (42.2%)
Divorced 13 (6.8%)
Widow 4 (2.1%)
Occupation, N (%)
Employed 86 (44.8%)
Unemployed 78 (40.6%)
Retired 8 (4.2%)
Student 20 (10.4%)
Monthly income, N (%)
< 3,000 Riyal 76 (39.6%)
3,000–6,000 Riyal 31 (16.1%)
6,000–9,000 Riyal 37 (19.3%)
>10,000 Riyal 48 (25%)
Smoking, N (%)
No 144 (75%)
Yes 36 (18.8%)
Previous smoker 12 (6.2%)
Year of diagnosis, N (%)
≤ 5 years 77 (40.1%)
>5 years 115 (59.9%)
MS type, N (%)
CIS 1 (0.5%)
PPMS 4 (2.1%)
RRMS 181 (94.3%)
SPMS 6 (3.1%)
Currently taking MS medications 167 (87%)
Ocrelizumab 99 (59.3%)
Interferon beta 27 (16.2%)
Fingolimod 19 (11.4%)
Natalizumab 18 (10.7%)
Others 24 (14.4%)
Not taking MS medication 25 (13%)
History of psychiatric disorders, N (%)
Yes 28 (14.6%)
No 164 (85.4%)
EDSS score
< 6 143 (81.3%)
≥6 33 (18.7%)